Comparing the current results to its competitors, Quantum Si Incorporated reported Revenue decrease in the 2 quarter 2026 year on year by -41.79 %, despite the revenue increase by the most of its competitors of 7.03 %, recorded in the same quarter.
Quantum si Incorporated, slower than the average decrease reported by the company's competitors of -77.45 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -77.45 %
Quantum Si Incorporated's Comment on Competition and Industry Peers
The company operates in the general life sciences technology market, facing competition from firms that supply components, products, and services for proteomics analysis. Key competitors include Agilent Technologies, Bio-Rad Laboratories, Danaher, Luminex, Merck KGaA and its subsidiary MilliporeSigma, Thermo Fisher Scientific, and Illumina, Inc. Emerging companies in proteomic products and solutions, such as Nautilus Biotechnology, Olink Proteomics (acquired by Thermo Fisher Scientific), Quanterix, Seer, and SomaLogic (acquired by Illumina, Inc.), also compete in this space. The legacy proteomics market includes providers of analytical instruments like mass spectrometry. Many competitors possess substantially greater financial, operational, and sales resources. The industry is highly competitive and expected to intensify with ongoing research and development. Principal competitive factors include the ability to address proteome complexity at scale, resolution and sensitivity, and the accuracy and reproducibility of results.
November 21, 2024
In the bustling arena of life sciences, a shimmering beacon of innovation has emerged: Quantum-Si Incorporated (Nasdaq: QSI), also known as The Protein Sequencing Company. During their recent Investor and Analyst event in New York City on November 20th, 2024, the company announced significant technical advances that promise to revolutionize the field of proteomics, a critical component in understanding complex biological systems.Central to this revelation is Quantum-Si s evolution of its existing technology, the Platinum Pro platform, alongside the introduction of an ambitious new proteomics platform dubbed Proteus. As the company pushes the boundaries of protein sequencing, industry experts and investors al...
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Danaher Corporation operates a diversified business model centered on developing advanced technologies and solutions across multiple sectors, particularly life sciences, diagnostics, dental, and environmental. The company emphasizes continuous innovation and operational excellence, leveraging its proprietary technologies to drive growth and improve efficiency. By strategically acquiring and integrating complementary businesses, Danaher enhances its product offerings while expanding its global market presence.
Merck & Co. Inc. operates primarily as a research-driven pharmaceutical company, focused on the development, manufacturing, and marketing of prescription drugs and vaccines globally. It aims to address unmet medical needs through innovative research, collaborations, and rigorous clinical trials, while promoting patient well-being and contributing to global healthcare with high-quality, affordable medications.
Nautilus Biotechnology Inc's business model focuses on using advanced genomics and proteomics technologies to analyze and understand the human proteome.
Quanterix Corp's business model is centered around developing and commercializing ultra-sensitive digital immunoassay platforms, which enable the detection and measurement of biomarkers with exceptional precision and accuracy.
Sources:
Quantum si Incorporated’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Quantum si Incorporated versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
